R Sanders Williams - Net Worth and Insider Trading
R Sanders Williams Net Worth
The estimated net worth of R Sanders Williams is at least $3 Million dollars as of 2025-05-05. R Sanders Williams is the Director of Labcorp Holdings Inc and owns about 6,431 shares of Labcorp Holdings Inc (LH) stock worth over $2 Million. R Sanders Williams is the Director of Amgen Inc and owns about 5,301 shares of Amgen Inc (AMGN) stock worth over $1 Million. R Sanders Williams is also the Director of Bristol-Myers Squibb Co and owns about 500 shares of Bristol-Myers Squibb Co (BMY) stock worth over $25,030. Details can be seen in R Sanders Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R Sanders Williams has not made any transactions after 2022-08-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of R Sanders Williams
R Sanders Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Sanders Williams owns 4 companies in total, including Amgen Inc (AMGN) , Labcorp Holdings Inc (LH) , and Bristol-Myers Squibb Co (BMY) among others .
Click here to see the complete history of R Sanders Williams’s form 4 insider trades.
Insider Ownership Summary of R Sanders Williams
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
AMGN | Amgen Inc | 2022-08-22 | director |
LH | Labcorp Holdings Inc | 2022-03-25 | director |
BMY | Bristol-Myers Squibb Co | 2006-09-11 | director |
![]() | ![]() | 2021-07-29 | director |
R Sanders Williams Latest Holdings Summary
R Sanders Williams currently owns a total of 3 stocks. Among these stocks, R Sanders Williams owns 6,431 shares of Labcorp Holdings Inc (LH) as of March 25, 2022, with a value of $2 Million and a weighting of 51.25%. R Sanders Williams owns 5,301 shares of Amgen Inc (AMGN) as of August 22, 2022, with a value of $1 Million and a weighting of 47.94%. R Sanders Williams also owns 500 shares of Bristol-Myers Squibb Co (BMY) as of September 11, 2006, with a value of $25,030 and a weighting of 0.81%.
Latest Holdings of R Sanders Williams
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LH | Labcorp Holdings Inc | 2022-03-25 | 6,431 | 246.82 | 1,587,299 |
AMGN | Amgen Inc | 2022-08-22 | 5,301 | 280.06 | 1,484,598 |
BMY | Bristol-Myers Squibb Co | 2006-09-11 | 500 | 50.06 | 25,030 |
Holding Weightings of R Sanders Williams
R Sanders Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, R Sanders Williams has made a total of 2 transactions in Labcorp Holdings Inc (LH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Labcorp Holdings Inc is the sale of 572 shares on March 25, 2022, which brought R Sanders Williams around $156,145.
According to the SEC Form 4 filings, R Sanders Williams has made a total of 7 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Amgen Inc is the sale of 200 shares on August 22, 2022, which brought R Sanders Williams around $49,992.
According to the SEC Form 4 filings, R Sanders Williams has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 0 shares on September 11, 2006, which brought R Sanders Williams around $0.
Insider Trading History of R Sanders Williams
- 1
R Sanders Williams Trading Performance
R Sanders Williams Ownership Network
Ownership Network List of R Sanders Williams
Ownership Network Relation of R Sanders Williams

R Sanders Williams Owned Company Details
What does Amgen Inc do?
Who are the key executives at Amgen Inc?
R Sanders Williams is the director of Amgen Inc. Other key executives at Amgen Inc include EVP & Research and Development David M Reese , EVP & Operations Esteban Santos , and SVP & Human Resources Derek Miller .
Amgen Inc (AMGN) Insider Trades Summary
Over the past 18 months, R Sanders Williams made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 5,802 shares made by Nancy A. Grygiel , a net sale of 35,045 shares made by Jonathan P Graham , and a net sale of 33,936 shares made by David M Reese .
In summary, during the past 3 months, insiders sold 78,487 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 78,487 shares. During the past 18 months, 94,289 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 94,289 shares.
Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amgen Inc Insider Transactions
R Sanders Williams Mailing Address
Above is the net worth, insider trading, and ownership report for R Sanders Williams. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, R Sanders Williams's mailing address is: Durham Nc 27706.